Michael L. Millenson

Suggest Changes
Learn More
BACKGROUND To determine the feasibility of combining concurrent carboplatin/paclitaxel and thoracic radiotherapy (TRT) for completely resected stage II and IIIA non-small cell lung cancer. METHODS(More)